Healthcare - Biotechnology - NASDAQ - AU
$ 2.05
-1.91 %
$ 313 M
Market Cap
-8.2
P/E
CASH FLOW STATEMENT
-34.8 M
OPERATING CASH FLOW
-21 M
INVESTING CASH FLOW
95.2 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Immutep Limited
| Net Income | -42.7 M |
| Depreciation & Amortization | 2.26 M |
| Capital Expenditures | -932 K |
| Stock-Based Compensation | 1.8 M |
| Change in Working Capital | 3.46 M |
| Others | 3.24 M |
| Free Cash Flow | -35.8 M |
Cash Flow
Millions
| Jun-2024 | Jun-2023 | Jun-2022 | Jun-2021 | Jun-2020 | Jun-2019 | Jun-2018 | Jun-2017 | Jun-2016 | Jun-2015 | Jun-2014 | Jun-2013 | Jun-2012 | Jun-2011 | Jun-2010 | Jun-2009 | Jun-2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||
| Net Income | (42.7) | (39.9) | (32.2) | (29.9) | (13.5) | (18.3) | (12.7) | (9.4) | (62.0) | (32.2) | (13.3) | (15.2) | (19.9) | (21.1) | (12.2) | (2.9) | (1.9) |
| Depreciation & Amortization | 2.3 | 2.1 | 2.1 | 2.1 | 2.1 | 1.9 | 1.8 | 1.7 | 2.0 | 1.3 | 0.4 | 0.3 | 0.4 | 64.2 K | 53 K | 49.4 K | 52.9 K |
| Deferred Income Tax | 0 | (5.0) | 0 | (7.3) | (6.1) | (5.7) | (9.8) | (0.2) | 0.8 | (1.0) | (0.9) | (1.4) | (0.4) | (10.6) | 2.5 | 0 | 0 |
| Stock Based Compensation | 1.8 | 2.0 | 2.2 | 1.7 | 1.7 | 1.6 | 2.3 | 0.9 | 49.5 | 0.7 | 57.3 K | 0.2 | 0.3 | 10.6 | 0.4 | 0 | 0 |
| Other Operating Activities | 0.4 | 4.2 | 8.04 K | 17.8 | 4.8 | 5.6 | 10.9 | 0.8 | 1.1 | 18.3 | 10.1 K | 27.1 K | 0.3 | 11.1 | 1.8 | 0.8 | 0.4 |
| Change in Working Capital | 3.5 | 0.8 | (1.6) | (2.0) | 94.2 K | (0.3) | (0.3) | (2.2) | (2.8) | 5.0 | (0.5) | 0.2 | 0.2 | 0.1 | 1.0 | 0.2 | (0.1) |
| Cash From Operations | (34.8) | (35.9) | (30.2) | (17.6) | (10.8) | (15.3) | (7.8) | (8.5) | (11.3) | (7.8) | (14.2) | (16.0) | (19.1) | (9.8) | (6.5) | (1.9) | (1.6) |
| INVESTING CASH FLOW | |||||||||||||||||
| Capital Expenditures | (0.9) | 47 K | 22.9 K | 15.6 K | 19.3 K | 41.4 K | 11.9 K | 6.64 K | 27.1 K | 48.5 K | (0.1) | (0.5) | (0.6) | 44.8 K | 95.3 K | 2.66 K | 4.57 K |
| Other Items | (20.1) | 16 K | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | (11.9) | (1.0) | 13.0 | (11.0) | 0 | (10.0) | 901 | 0 |
| Cash From Investing Activities | (21.0) | 31 K | 22.9 K | 15.6 K | 19.3 K | 41.4 K | 11.9 K | 6.64 K | 0.1 | (12.0) | (1.1) | 12.5 | (11.6) | 44.8 K | (10.1) | 1.76 K | 4.57 K |
| FINANCING CASH FLOW | |||||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (0.2) | (0.2) | (0.2) | (0.2) | 77.5 K | 0 | 0 | 0 | 12.2 | 3.7 | 0 | 0 | 0 | 5.4 | 6.3 | 1.7 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (4.8) | (3.8) | (2.4) | 9.6 | (1.5) | 3.1 | 1.4 | 8.53 K | (0.3) | (0.2) | (0.2) | (0.6) | 6.93 K | (1.9) | (0.2) | (1.7) | (0.2) |
| Cash From Financing Activities | 95.2 | 76.0 | 50.3 | 52.7 | 20.5 | 8.0 | 18.4 | 8.53 K | 25.7 | 11.3 | 6.7 | 7.2 | 1.8 | 50.1 | 21.3 | 1.7 | 2.0 |
| CHANGE IN CASH | |||||||||||||||||
| Net Change In Cash | 38.4 | 43.4 | 19.4 | 34.3 | 9.8 | (6.9) | 11.2 | (8.6) | 14.1 | (7.4) | (7.8) | 5.0 | (28.9) | 40.3 | 4.7 | (0.2) | 0.4 |
| FREE CASH FLOW | |||||||||||||||||
| Free Cash Flow | (35.8) | (35.9) | (30.3) | (17.7) | (10.9) | (15.3) | (7.8) | (8.5) | (11.3) | (7.8) | (14.3) | (16.5) | (19.7) | (9.8) | (6.6) | (1.9) | (1.6) |